| Valuation method | Value, £ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 70.47 | 30 |
| Intrinsic value (DCF) | 28.62 | -47 |
| Graham-Dodd Method | 0.22 | -100 |
| Graham Formula | 4.54 | -92 |
Calculus VCT plc (LSE: CLC.L) is a UK-based venture capital trust (VCT) specializing in early-stage and growth-oriented investments, primarily in small and medium-sized enterprises (SMEs). Formerly known as Investec Structured Products Calculus VCT PLC, the company operates under the UK's VCT scheme, which provides tax-efficient investment opportunities for individual investors. Calculus VCT focuses on sectors such as technology, healthcare, and business services, offering capital appreciation and dividend income. As part of the Financial Services sector, Calculus VCT plays a crucial role in funding innovative UK businesses while providing investors with exposure to high-growth potential ventures. The company's investment strategy emphasizes diversification and long-term value creation, making it a key player in the UK's venture capital ecosystem.
Calculus VCT plc presents a niche investment opportunity for UK investors seeking tax-efficient exposure to early-stage ventures. The company's focus on SMEs aligns with the UK government's incentives for VCTs, offering potential capital gains and dividend income. However, the FY 2024 financials show a net loss of £493,846 (GBp) and negative operating cash flow, indicating challenges in portfolio performance. The diluted EPS of -0.0082 GBp further underscores profitability concerns. While the dividend yield (2.7814 GBp per share) may attract income-focused investors, the high-risk nature of venture capital investments and market volatility (beta: 0.016) suggest cautious consideration. Investors should weigh the tax benefits against the inherent risks of early-stage investing.
Calculus VCT plc operates in a competitive landscape dominated by larger VCTs and private equity firms. Its competitive advantage lies in its specialized focus on UK SMEs and tax-efficient structure, appealing to retail investors. However, its small market cap (£44.68M) limits its ability to compete with larger VCTs like Octopus Titan VCT or Foresight Group, which have broader portfolios and greater resources. Calculus VCT's negative earnings and cash flow position it as a higher-risk player in the sector. The lack of debt (total debt: 0) provides financial flexibility but may also indicate constrained growth capital. The company's ability to source high-quality deals and manage portfolio exits will be critical in differentiating itself from peers. Its low beta suggests minimal correlation with broader markets, which could appeal to investors seeking diversification, but also reflects limited liquidity and investor interest.